Back to Trades
Froimson Mark
DirectorCIK 0001709050
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2026
Across 2 filings between 2026, Froimson Mark, Director, has disclosed $266.0K in transactions — all concentrated in Pacira BioSciences, Inc. (PCRX). Their disclosed trades are heavily weighted toward selling — $0 in buys and $10.9K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Jun 12 | PCRX Pacira BioSciences, Inc. | Froimson Mark | Director | Grant | $255.1K |
| Mar 19 | PCRX Pacira BioSciences, Inc. | Froimson Mark | Director | Sell | $10.9K |
2 filings